UBS Group’s MorphoSys MOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-3,317
Closed -$60.4K – 10427
2024
Q2
$60.4K Sell
3,317
-1,164,695
-100% -$21.2M ﹤0.01% 6544
2024
Q1
$21.2M Buy
1,168,012
+1,167,212
+145,902% +$17.3M 0.01% 1639
2023
Q4
$7.92K Sell
800
-103
-11% -$757 ﹤0.01% 7598
2023
Q3
$6.07K Sell
903
-1,084
-55% -$8.35K ﹤0.01% 7322
2023
Q2
$14.8K Sell
1,987
-412
-17% -$2.51K ﹤0.01% 7002
2023
Q1
$9.5K Buy
2,399
+1,557
+185% +$6.86K ﹤0.01% 7648
2022
Q4
$3.01K Sell
842
-4,299
-84% -$19.2K ﹤0.01% 9581
2022
Q3
$26K Buy
5,141
+2,832
+123% +$14.6K ﹤0.01% 7070
2022
Q2
$11K Buy
2,309
+1,467
+174% +$8.1K ﹤0.01% 7875
2022
Q1
$5K Sell
842
-3,986
-83% -$29.5K ﹤0.01% 9188
2021
Q4
$46K Buy
4,828
+4,028
+504% +$42.7K ﹤0.01% 6993
2021
Q3
$9K Sell
800
-20
-2% -$290 ﹤0.01% 8129
2021
Q2
$15K Sell
820
-6
-0.7% -$128 ﹤0.01% 7663
2021
Q1
$18K Sell
826
-1,175
-59% -$31.4K ﹤0.01% 7481
2020
Q4
$56K Buy
2,001
+1,160
+138% +$31.8K ﹤0.01% 6090
2020
Q3
$26K Buy
841
+15
+2% +$486 ﹤0.01% 6111
2020
Q2
$26K Buy
826
+26
+3% +$758 ﹤0.01% 6386
2020
Q1
$20K Hold
800
– – ﹤0.01% 6505
2019
Q4
$29K Hold
800
– – ﹤0.01% 6665
2019
Q3
$22K Sell
800
-722
-47% -$20.7K ﹤0.01% 6689
2019
Q2
$36K Sell
1,522
-104
-6% -$2.58K ﹤0.01% 6199
2019
Q1
$37K Buy
+1,626
New +$42.7K ﹤0.01% 5776
2018
Q3
– Sell
-762
Closed -$23K – 8339
2018
Q2
$23K Buy
+762
New +$20.9K ﹤0.01% 6613

Other funds holding MOR

UBS Group's MOR Position: Q3 2024 in Review

UBS Group sold out of MorphoSys (MOR) in Q3 2024, closing a stake of 3,317 shares — an estimated $60.4K sold.

UBS Group first reported a position in MOR in Q2 2018 and held it in 23 quarters. The position peaked at $21.2M in Q1 2024. 9 funds tracked by Wall St. Rank hold MOR as of Q3 2024.

  • UBS Group reported no remaining MorphoSys position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 3,317 MorphoSys shares in Q3 2024, an estimated $60.4K.
  • UBS Group first reported a position in MorphoSys in Q2 2018 and held it in 23 quarters.
  • UBS Group's MorphoSys position peaked at $21.2M in Q1 2024.
  • 9 funds tracked by Wall St. Rank held MorphoSys as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.